リストに無い構造でもお気軽にお問い合わせください。リスト品と同等の価格、納期でご提供できるかもしれません。
お気軽にどうぞ。
category = @13
SCHEM No. | Structure | Compound Name | Price (JPY) | Purity | Stock(mg) |
---|---|---|---|---|---|
05950 | Sulforhodamine bis(CO-PEG14-COOH) | 64,600/0.1mg | >95% | 1.6 | |
07609 | Glutathione tridecasulfide | 119,600/0.1mg | <80% | 0.7 | |
06798 | Cy5(1-PEG3-OMe 5-SO3H 8,8-diMe 1'-PEG13-COOH 8',8'-diMe) | 119,600/0.1mg | >95% | 0.1 | |
06461 | Cy5(PEG3-OMe)(PEG13-COOtBu) | 119,600/0.1mg | >95% | 0 | |
06410 | Cy7(1-PEG13-COOH 5-SO3H 8,8-diMe 1'-PEG3-OMe 5'-SO3H 8',8'-diMe) | 119,600/0.1mg | >95% | 0.4 | |
06401 | TMSI-PEG13-OTrt | 64,600/0.1mg | >95% | 0 | |
06396 | AADIS7-PEG13-COOH | 119,600/0.1mg | >95% | 0.3 | |
06390 | AADIS7-PEG13-COOtBu | 96,000/0.1mg | >95% | 0.9 | |
06311 | TMSI-PEG13-COOH | 64,600/0.1mg | >95% | 11.1 | |
06064 | Cy7(1-HexCONH-PEG13-COOtBu 5-SO3H 8,8-diMe 1'-Et-SO3H 8',8'-diMe) | 96,000/0.1mg | >95% | 0 | |
05373 | Cy5(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG13-CONH-PEG2-Hex-Cl 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 119,600/0.1mg | >90% | 0.1 | |
05078 | Cy5(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG13-COOtBu 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 96,000/0.1mg | >90% | 0 | |
04746 | CF660R-PEG13-PEG2-O-HexCl | 119,600/0.1mg | >95% | 0.1 | |
04731 | DY-547-CONH-PEG13-COOH | 69100/<0.1mg | >95% | 0.1 | |
04730 | Texas-Red-X-CONH-PEG13-COOH mixed isomers | 69100/<0.1mg | >95% | 0.1 | |
07608 | Glutathione dodecasulfide | 119,600/0.1mg | <80% | 0.6 | |
06479 | Cy5(1-PEG12-OMe 5-SO3H 8,8-diMe 1'-AcOtBu-8',8'-diMe | 64,600/0.1mg | >90% | 0.4 | |
06456 | TMSI-PEG12-OMe | 64,600/0.1mg | >80% | 9.0 | |
06394 | TMSI-PEG12-OH | 119,600/0.1mg | >95% | 6.1 | |
06363 | SH-PEG12-SH | 70,300/2.5mg | >90% | 0 | |
06354 | Cyclic(-S-PEG12-S-) | 67,300/0.1mg | >95% | 0 | |
06338 | SCSOEt-PEG12-SCSOEt | 64,600/0.5mg | >90% | 0 | |
07607 | Glutathione undecasulfide | 122,300/0.1mg | <80% | 0.7 | |
06518 | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Et 5'-SO3H 8'-Me 8'-PEG11-OMe | 64,600/0.1mg | >90% | 0 | |
06362 | SH-PEG11-SH | 67,300/0.2mg | >90% | 0 | |
07606 | Glutathione decasulfide | 122,300/0.1mg | <80% | 0.9 | |
06402 | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG10-OAc 5'-SO3H 8',8'-diMe) | 64,600/0.1mg | >95% | 0 | |
06361 | SH-PEG10-SH | 67,300/0.5mg | >90% | 0 | |
06356 | Cyclic(-S-PEG10-) | 80,700/0.1mg | >95% | 0 | |
06355 | Cyclic(-S-PEG4-S-PEG6-) | 80,700/0.1mg | >95% | 0 | |
06069 | TMSI-PEG10-OH | 64,600/0.1mg | >95% | 0.1 | |
07603 | Glutathione nonasulfide | 122,300/0.1mg | >80% | 1.5 | |
06375 | Cyclic(-S-PEG9-) | 80,700/0.1mg | >95% | 3.5 | |
06068 | TMSI-PEG10-OTrt | 64,600/0.3mg | >95% | 9.0 | |
02749 | OH-PEG9-SO3H | 63,300/0.9mg | >95% | 16.2 | |
01749 | SCSOEt-PEG9-SCSOEt | 67,600/2.5mg | >95% | 0 | |
01724 | SH-PEG9-SH | 70,300/2.5mg | >90% | 44.3 | |
07524 | Glutathione octasulfide | 88,300/0.1mg | >90% | 1.7 | |
06360 | SH-PEG8-SH | 83,700/2.5mg | >90% | 0 | |
06349 | Cyclic(-S-PEG5-S-PEG3-) | 80,700/0.1mg | >95% | 0 | |
06295 | TMSI-PEG8-OH | 63,300/0.9mg | >95% | 12.8 | |
00369 | N3-PEG8-COOH | 73,600/2.5mg | >95% | 0 | |
06866 | Glutathione heptasulfide | 88,300/0.1mg | >90% | 3.2 | |
06398 | TMSI-PEG7-OH | 63,300/0.9mg | >95% | 1.3 | |
06359 | SH-PEG7-SH | 79,400/0.9mg | >90% | 0 | |
06350 | Cyclic(-S-PEG7-S-PEG1-) | 80,700/0.1mg | >95% | 0 | |
06865 | Glutathione hexasulfide | 88,300/0.1mg | >90% | 8.6 | |
06516 | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG6-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >90% | 0 | |
06432 | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 | |
06417 | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG6-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >95% | 0 | |
06397 | TMSI-PEG6-OH | 63,300/0.9mg | >95% | 1.2 | |
01794 | SH-PEG6-SH | 63,300/0.9mg | >90% | 0 | |
06862 | Glutathione pentasulfide | 72,200/0.1mg | >90% | 19.0 | |
06796 | AADIS5-PEG5-COOH | 63,300/0.9mg | >95% | 0 | |
06453 | SCNHNH2-PEG5-SCNHNH2 | 74,700/50mg | >95% | 335.0 | |
06426 | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG5-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >95% | 0 | |
06419 | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG5-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >90% | 0 | |
06377 | Cyclic(-S-PEG5-) | 80,700/0.1mg | >95% | 0 | |
06357 | SH-PEG5-SH | 63,300/0.9mg | >90% | 0 | |
06294 | TMSI-PEG5-NHTrt | 64,600/0.1mg | >95% | 2.6 | |
05343 | DMT-PEG5-S-PEG4-ODMT | 64,600/500mg | >80% | 2,114.2 | |
04857 | Sulforhodamine bis(piperazine-PEG5-COOH) | 64,600/0.5mg | >95% | 7.0 | |
04743 | DMT-PEG5-S-Et-OH | 72,000/50mg | >90% | 300.6 | |
06863 | L-Cysteine tetrasulfide | 64,600/0.1mg | >95% | 0 | |
06861 | Glutathione tetrasulfide | 67,300/0.5mg | >90% | 60.1 | |
06511 | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | 64,600/0.1mg | >90% | 0 | |
06509 | 1-(5-carboxypentyl)-2-[(E,3Z)-3-[1-ethyl-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 | |
06508 | Tos-PEG4-SCSOEt | 67,600/25mg | >95% | 271.5 | |
06473 | DMSI(3-PEG4-COOH) | 63,300/0.9mg | >95% | 4.1 | |
06434 | 2-[(E,3Z)-3-[1,3-bis[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-1-[2-[2-(2-carboxyethoxy)ethoxy]ethyl]-3-[2-(2-methoxyethoxy)ethyl]-3-methyl-indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 | |
06433 | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-Et 5'-SO3H 8'-Me 8'-PEG3-OMe) | 64,600/0.1mg | >90% | 0 | |
06422 | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >90% | 0 | |
06409 | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG4-N3 8',8'-diMe) | 119,600/0.1mg | >95% | 0 | |
06405 | AADIS7-PEG4-N3 | 64,600/0.1mg | >95% | 2.5 | |
06387 | SCSOEt-PEG4-SCSOEt | 72,000/50mg | >90% | 669.7 | |
06384 | Cyclic(-S-PEG4-S-)9 | 135,700/0.1mg | >95% | 0.1 | |
06383 | Cyclic(-S-PEG4-S-)8 | 135,700/0.1mg | >90% | 0.1 | |
06382 | Cyclic(-S-PEG4-S-)7 | 135,700/0.1mg | >90% | 0.1 | |
06381 | Cyclic(-S-PEG4-S-)6 | 135,700/0.1mg | >90% | 0.1 | |
06380 | Cyclic(-S-PEG4-S-)5 | 135,700/0.1mg | >90% | 0.1 | |
06379 | Cyclic(-S-PEG4-S-)4 | 135,700/0.1mg | >90% | 0.1 | |
06378 | Cyclic(-S-PEG4-S-)3 | 135,700/0.1mg | >90% | 0.1 | |
06353 | Cyclic(-S-PEG4-S-)4 | 77,800/0.1mg | >95% | 0 | |
06352 | Cyclic(-S-PEG4-S-)3 | 77,800/0.1mg | >95% | 0 | |
06343 | Cyclic(-S-PEG4-S-)2 | 135,700/0.1mg | >95% | 0.1 | |
06340 | SH-PEG4-SS-PEG4-SH | 83,400/0.9mg | >90% | 34.0 | |
06293 | TMSI-PEG4-Pr-COOH | 63,300/0.9mg | >95% | 0 | |
06062 | Cy7(1-PEG4-COOH 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 96,000/0.1mg | >95% | 0.1 | |
06059 | AADIS7-PEG4-COOMe | 119,600/0.1mg | >95% | 3.9 | |
06009 | Cy7(1-PEG4-COOMe 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 96,000/0.1mg | >95% | 0 | |
05970 | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-PEG4-OH 8',8'-diMe) | 64,600/0.1mg | >95% | 0 | |
05948 | TMSI-PEG4-OH | 64,600/0.2mg | >95% | 15.7 | |
05344 | DMT-PEG4-S-Et-OAc | 64,600/100mg | >80% | 426.3 | |
05075 | AADIS7-PEG3-OAc | 64,600/0.5mg | >95% | 3.0 | |
04712 | SH-PEG4-SH | inquire | >90% | 60.0 | |
04674 | SCNHNH2-PEG4-SCNHNH2 | 74,700/50mg | >95% | 1,350.9 | |
04673 | Tos-PEG4-SCNHNH2 | 64,600/75mg | >95% | 776.1 | |
03828 | Trt-PEG3-S-Et-OH | 74,600/25mg | >90% | 408.1 | |
03545 | TMSI-PEG4-COOMe | 64,600/0.1mg | >95% | 1.6 | |
02292 | DMT-PEG4-SS-PEG4-OTos | 67,700/5mg | >95% | 30.8 | |
02196 | Trt-PEG4-SH | 64,000/0.2mg | >95% | 1.8 | |
02194 | DMT-PEG4-SS-Et-OH | 65,600/25mg | >95% | 371.1 | |
02193 | Trt-PEG4-SS-Et-OTos | 67,700/5mg | >95% | 0 | |
01266 | Trt-PEG4-SS-PEG4-N3 | 66,300/2.5mg | >90% | 0 | |
06860 | Glutathione trisulfide | 67,300/10mg | >90% | 89.5 | |
06512 | 3-(5-carboxypentyl)-1-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethyl]-2-[(1E,3E,5E)-5-[3-(2-methoxyethyl)-1-methyl-1-(3-sulfopropyl)benzo[e]indol-2-ylidene]penta-1,3-dienyl]-1-methyl-8-sulfo-benzo[e]indol-3-ium-6-sulfonate | 64,600/0.1mg | >90% | 0 | |
06450 | (OH-PEG3-S-)2 | 79,400/0.9mg | >95% | 7.2 | |
06431 | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >95% | 0 | |
06430 | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >90% | 0 | |
06425 | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >95% | 0 | |
06423 | Cy7(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG3-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >95% | 0 | |
06421 | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 | |
06420 | (3R)-1-(5-carboxypentyl)-2-[(E,3E)-3-[(3S)-1-[2-[2-(2-methoxyethoxy)ethoxy]ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 | |
06393 | TMSI-PEG3-OMe | 63,300/0.9mg | >95% | 11.2 | |
06358 | SH-PEG3-SH | inquire | >90% | 1.3 | |
06351 | Cyclic(-S-PEG3-S-PEG1-)2 | 80,700/0.1mg | >95% | 0 | |
06346 | Cyclic(-S-PEG3-S-CH2-O-CH2-)2 | 80,700/0.1mg | >95% | 0 | |
06342 | Cyclic(-S-PEG3-S-)2 | 80,700/0.1mg | >95% | 0 | |
06341 | SH-PEG3-SS-PEG3-SH | 83,400/0.9mg | >90% | 0 | |
06061 | Cy7(1-Hex-COOH 5-SO3H 8,8-diMe 1'-PEG3-OAc 5'-SO3H 8',8'-diMe) | 96,000/0.1mg | >95% | 0.1 | |
05146 | TMSI-PEG3-OH | 64,600/0.1mg | >95% | 89.4 | |
03842 | N3-PEG3-O-Et-SS-Et-PEG3-OH | 70,400/5mg | >95% | 38.9 | |
03032 | DMT-PEG3-NH-Et-SS-Et-NH2 | 66,300/2.5mg | >95% | 37.9 | |
02597 | Trt-PEG3-PPG1-SO3H | 64,600/10mg | >95% | 186.0 | |
02345 | TrtNH-PEG3-NHCO-Et-S-COMe | 65,200/7.5mg | >95% | 98.0 | |
02065 | Trt-PEG3-SSO3H | 63,100/0.6mg | >95% | 26.8 | |
01905 | N3-PEG3-SCSOEt | 65,700/0.6mg | >95% | 77.4 | |
01636 | SO3H-PEG3-OH | 65,700/0.6mg | <80% | 60.0 | |
01331 | Cy5(1-Hex-CONH-PEG3-NH2 5-SO3H 8,8-diMe 1'-Me 5'-SO3H 8',8'-diMe) | 63,300/0.9mg | >90% | 0 | |
06515 | 2-[(E,3E)-3-[3,3-dimethyl-5-sulfo-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-1-[2-[2-(4-sulfobutoxy)ethoxy]ethyl]indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 | |
06513 | 3-[2-[(1E,3E,5Z)-5-[3,3-dimethyl-5-sulfo-1-(3-sulfopropyl)indolin-2-ylidene]penta-1,3-dienyl]-3-[5-[2-(2-hydroxyethoxy)ethylamino]-5-oxo-pentyl]-3-methyl-5-sulfo-indol-1-ium-1-yl]propane-1-sulfonate | 64,600/0.1mg | >95% | 0 | |
06510 | Cy7(1-Pr-SO3H 5-SO3H 8-Me 8-Hex-CONH-PEG2-OMe 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 64,600/0.1mg | >95% | 0 | |
06440 | Cy7(1-HexCOOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG2-OMe 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >95% | 0 | |
06439 | Cy5(1-Hex-COOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG2-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >90% | 0 | |
02195 | TrtNH-PEG1-S-Et-OH | 65,600/25mg | >90% | 136.0 | |
04961 | 2-(2-trityloxyethyldisulfanyl)ethanol | 64,600/100mg | >95% | 178.4 | |
01699 | SCSOEt-PEG2K-SCSOEt | 72,000/5mg | <80% | 353.0 | |
07517 | Dichloroprop methyl ester D3 | 72,000/5mg | >95% | 0 | |
06851 | Dichloroprop methyl ester | inquire | >95% | 138.1 | |
06843 | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-EtOAc 8',8'-diMe) | 64,600/0.3mg | >95% | 1.9 | |
06841 | AADIS5(6-Br)(8-N-Pr-SO3H) | 63,300/0.9mg | >95% | 9.1 | |
06840 | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-EtOH 8',8'-diMe) | 64,600/0.5mg | >95% | 0.7 | |
06790 | 3-(5-bromo-2,3,3-trimethyl-pyrrolo[2,3-b]pyridin-7-yl)propane-1-sulfonic acid | 63,300/0.9mg | >95% | 156.7 | |
06607 | 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]ethanesulfonic acid | 67,600/7.5mg | >95% | 0.2 | |
06523 | Cy7(1-PEG4-COOH 5-SO3H 8,8-di-Me 1'-PEG4-COOH 5'-SO3H 8',8'-diMe)(4-Et-SO3H) | 64,600/0.1mg | >95% | 0 | |
06522 | Cy7(1-HexCOOH 5-SO3H 8-Me 8-Pr-SO3H 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-Pr-SO3H) | 64,600/0.1mg | >95% | 0 | |
06521 | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 | |
06520 | Cy5(1-PEG4-Pr-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-PE4-OMe 5'-SO3H 8'-Me 8'-PEG4-OMe) | 64,600/0.1mg | >90% | 0 | |
06519 | Cy7(1-HexCOOH 5-SO3H 8-Me 8-PEG4-OMe 1'-Et 5'-SO3H 8'-Me 8'-PEG4-OMe) | 64,600/0.1mg | >95% | 0 | |
06517 | 1-(4-aminobutyl)-2-[(1E,3E,5E)-5-[1-(5-carboxypentyl)-3,3-dimethyl-indolin-2-ylidene]penta-1,3-dienyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | 119,600/0.1mg | >95% | 0 | |
06514 | 1-ethyl-2-[(E,3E)-3-[1-[6-(2-hydroxyethoxy)-6-oxo-hexyl]-3,3-dimethyl-5-sulfo-indolin-2-ylidene]prop-1-enyl]-3,3-dimethyl-indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 | |
06490 | 3',6'-bis(3-sulfanylpropoxy)spiro[isobenzofuran-3,9'-xanthene]-1-one | 119,600/0.1mg | >95% | 0 | |
06446 | 3-[2-[2-[(2E)-2-[(E)-3-[3,3-dimethyl-1-[2-[2-(3-sulfopropoxy)ethoxy]ethyl]indol-1-ium-2-yl]prop-2-enylidene]-3,3-dimethyl-indolin-1-yl]ethoxy]ethoxy]propane-1-sulfonic acid | 64,600/0.1mg | >95% | 0 | |
06442 | [3-oxo-6'-(3-sulfanylpropanoyloxy)spiro[isobenzofuran-1,9'-xanthene]-3'-yl] 3-sulfanylpropanoate | 119,600/0.1mg | >95% | 0 | |
06418 | Cy7(1-PEG5-COOH 5-SO3H 8-Me 8-PEG4-OMe 1'-PEG4-OMe 5'-SO3H 8'-Me 8'-PEG4-OMe) | 64,600/0.1mg | >95% | 0 | |
06416 | 1-(5-carboxypentyl)-2-[(E,3E)-3-[1-[2-(2-methoxyethoxy)ethyl]-3-methyl-5-sulfo-3-(3-sulfopropyl)indolin-2-ylidene]prop-1-enyl]-3-methyl-3-(3-sulfopropyl)indol-1-ium-5-sulfonate | 64,600/0.1mg | >95% | 0 | |
06297 | AADIS5-Et-OAc | 64,600/0.2mg | >95% | 8.0 | |
06296 | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Pr-SO3H 5'-SO3H 8',8'-diMe) | 96,000/0.1mg | >90% | 0.9 | |
06167 | 1-phenyl-5-propylsulfonyl-tetrazole | 64,600/50mg | >95% | 617.8 | |
06162 | 5-butylsulfonyl-1-phenyl-tetrazole | 64,600/50mg | >95% | 1,246.2 | |
06145 | 5-ethylsulfanyl-1-phenyl-tetrazole | 64,600/50mg | >95% | 300.0 | |
06114 | AADIS7-Et-SO3H | 64,600/0.1mg | >80% | 7.6 | |
06035 | TMSI-Et-SO3H | 64,600/0.5mg | >80% | 20.4 | |
05969 | AADIS5-Hex-COOH | 63,300/0.9mg | >95% | 1.0 | |
05968 | 2-[4-[6'-[4-(carboxymethyl)piperazin-1-yl]-1,1-dioxo-spiro[2,1-ramda-benzoxathiole-3,9'-xanthene]-3'-yl]piperazin-1-yl]acetic acid | 64,600/0.1mg | >95% | 1.0 | |
05967 | 2-[4-(1,1-dioxo-6'-piperazin-1-yl-spiro[2,1-ramda--benzoxathiole-3,9'-xanthene]-3'-yl)piperazin-1-yl]acetic acid | 64,600/0.1mg | >95% | 0 | |
05959 | AADIS5-Me | 64,600/0.2mg | >95% | 9.3 | |
05955 | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-Hex-COOH 5'-SO3H 8',8'-diMe) | 64,600/0.2mg | >90% | 0.1 | |
05954 | AADIS7-Hex-COOH | 64,600/0.1mg | >95% | 0.1 | |
05945 | TMSI-acetoxyacetic acid | 64,600/0.1mg | >95% | 5.3 | |
05944 | TMSI-Me | inquire | >95% | 3.3 | |
05941 | AADIS5-HexCOOH | 63,300/0.9mg | >95% | 31.2 | |
05940 | Cy5(1-Hex-COOH 5-SO3H 8,8-diMe 1'-Hex-COOH 5'-SO3H 8',8'-diMe) | 63,300/0.9mg | >90% | 0.5 | |
05923 | (Boc-Cys-OBn)2 | 67,600/25mg | >95% | 1.3 | |
05393 | Cy7(1-HexCOOH 5-SO3H 8,8-diMe 1'-Et-SO3H 8',8'-diMe) | 64,600/0.1mg | >95% | 0.1 | |
05374 | 2-[[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-(4-methylsulfonylphenyl)ethyl]amino]-2-oxo-acetic acid | 65,200/7.5mg | >95% | 73.3 | |
05372 | N-[(1S,2R)-1-(fluoromethyl)-2-hydroxy-2-(4-methylsulfonylphenyl)ethyl]-2-hydroxy-acetamide | 65,600/25mg | >95% | 82.4 | |
05371 | Tos-O-Et-SS-Et-OTos | 72,000/50mg | >95% | 291.6 | |
05364 | AADIS5-Et-SO3H | 96,000/0.1mg | >95% | 2.4 | |
05342 | Sodium 4-dodecylbenzenesulfonate | inquire | >95% | 30.0 | |
05314 | p-n-Dodecylbenzenesulfonic Acid Sodium Salt 13C6 | inquire | >95% | 5.8 | |
05148 | Sulfo-Cy3 bis(IAA) | 64,600/0.2mg | >95% | 0.1 | |
05147 | Sulfo Cy3-diamine | 64,600/0.2mg | >95% | 5.0 | |
05143 | Sulfo-Cy3 | 64,600/0.5mg | >95% | 2.6 | |
05142 | TMSI-Et-OH | 72,000/5mg | >95% | 325.6 | |
05141 | TMSI-acetic acid | 64,600/0.3mg | >95% | 13.3 | |
05132 | TMSI-Et-NH2 | 64,600/5mg | >95% | 22.7 | |
05130 | Suflo-Cy3 | 63,300/0.9mg | >95% | 4.7 | |
05094 | PFOS | 63,300/0.9mg | >99% | 2.8 | |
05072 | AADIS7-Me | 64,600/0.3mg | >95% | 1.7 | |
05048 | Bentazone-D7 | 88,000/20mg | >95% | 0 | |
05047 | Isoprothiolane-D4 | 55,000/20mg | >95% | 0 | |
05033 | Ampicillin-D5 | 77,000/10mg | >95% | 0 | |
04939 | Mono-6-SH-gamma-cyclodextrin | 67,900/7.5mg | >90% | 170.0 | |
04938 | Mono-6-SH-alpha-cyclodextrin | 65,200/7.5mg | >90% | 161.0 | |
04925 | Thiuram-D12 | 64,600/10mg | >95% | 160.0 | |
04891 | 2-S-Cysteinyldopa | 81,600/0.1mg | >95% | 25.0 | |
04876 | Mono-6-SH-beta-cyclodextrin | 65,200/7.5mg | >90% | 112.0 | |
04852 | bis-(IAA-piperazinyl) sulforhodamine | 64,600/0.3mg | >95% | 0.9 | |
04282 | Mono TSE succinic acid | 64,600/75mg | >95% | 1,400.0 | |
04148 | 3-[(7-aminophenothiazin-5-ium-3-yl)-(3-sulfopropyl)amino]propane-1-sulfonate(mix isomers) | 64,600/0.1mg | >95% | 3.8 | |
04136 | TMSI-Hex-COOH | inquire | >90% | 740.6 | |
04084 | Ethanesulfonic acid, 2-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]- | 64,600/10mg | >95% | 400.0 | |
04080 | Ethanesulfonic acid, 2-[[(1,1-dimethylethoxy)carbonyl]amino]- | 65,600/25mg | >95% | 300.0 | |
03976 | n-Octylxanthate potassium salt | 64,600/50mg | >95% | 456.4 | |
03666 | 1-amino-4-(dimethylamino)-2-sulfosulfanyl-benzene | 66,400/500mg | >95% | 5,749.6 | |
03607 | TMSI-K salt | inquire | >90% | 6,570.9 | |
02909 | GSH-S-Bimane | 63,300/0.9mg | >95% | 30.3 | |
02363 | S-tritylmercaptopropionic acid | inquire | >95% | 1,000.0 | |
02358 | rac-(2S)-4-tert-butoxy-2-[[4-tert-butoxy-4-oxo-2-[6-[[rac-(2S)-5-acetylsulfanyl-2-(9H-fluoren-9-ylmethoxycarbonylamino)pentanoyl]amino]hexanoylamino]butanoyl]amino]-4-oxo-butanoic acid | 64,600/0.1mg | >95% | 6.0 | |
02331 | Acetylmercaptopropionic acid | inquire | >95% | 856.0 | |
01980 | Cy3-halolinker | 64,600/0.3mg | >95% | 0.1 | |
01516 | Arsenosugar monosulfate | 200,000/<0.1mg | >95% | 0.2 | |
00656 | N-[2-(2-aminoethyldisulfanyl)ethyl]-4-[3-(trifluoromethyl)diazirin-3-yl]benzamide | 65,600/25mg | >95% | 806.0 | |
00651 | 4-Amino-N-(5-methyl-isoxazol-3-yl)-benzenesulfonamide-d4 | 68,000/10mg | >95% | 817.0 | |
00583 | C10-SPC | 75,000/10mg | >95% | 15.0 | |
00582 | C8-SPC | 96,000/0.1mg | >95% | 105.0 | |
00413 | 1H-Imidazolium, 1,2-dimethyl-3-[(2,2,2-trichloroethoxy)sulfonyl]-, 1,1,1-trifluoromethanesulfonate | 65,600/25mg | >95% | 466.0 | |
00352 | 2,2,2-Trichloroethyl chlorosulfate | inquire | <80% | 2,521.7 |